Extra data supporting utility of PAM50 gene signature for breast cancer to be presented at ASCO 2011 NanoString Technologies, Inc Read more ., a privately held company of life science tools for translational analysis and programmer of molecular diagnostics, today announced that researchers will present additional proof for the potential utility of profiling breasts cancer predicated on the PAM50 gene signature at the 2011 American Society of Clinical Oncology annual meeting occurring in Chicago, From June 3-7 Illinois.
‘Their bodies taken care of immediately insulin better than they would have before they got the leucine. It improved their ability to metabolize sugar and fats. It markedly improved their pre-diabetic condition. Their metabolic syndrome also improved.’ Mice who were fed a normal diet plan and given leucine demonstrated no significant results from taking the dietary product. Kahn said the study sought to discover what effect just a small change within their environment – – in cases like this in only one small element of the diet – – might have on animals with prediabetes or metabolic syndrome. ‘We discovered that adding just this one amino acid to the dietary plan changed the fat burning capacity in a lot of different pathways,’ he said.